ONCOTHERAPY SCIENCE INC revenue for the last year amounted to 1.13 B JPY, the most of which — 1.13 B JPY — came from its highest performing source at the moment, Cancer Precision Medical Services, the year earlier bringing 1.15 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought ONCOTHERAPY SCIENCE INC 1.13 B JPY, and the year before that — 1.15 B JPY.